Skip to main content
Top
Published in: Journal of General Internal Medicine 5/2007

01-05-2007 | Original Article

Awareness, Accuracy, and Predictive Validity of Self-Reported Cholesterol in Women

Authors: Peng-yun A. Huang, MBBS, MPH, Julie E. Buring, ScD, Paul M. Ridker, MD, MPH, Robert J. Glynn, PhD, ScD

Published in: Journal of General Internal Medicine | Issue 5/2007

Login to get access

Abstract

Background

Although current guidelines emphasize the importance of cholesterol knowledge, little is known about accuracy of this knowledge, factors affecting accuracy, and the relationship of self-reported cholesterol with cardiovascular disease (CVD).

Methods

The 39,876 female health professionals with no prior CVD in the Women’s Health Study were asked to provide self-reported and measured levels of total and high-density lipoprotein (HDL) cholesterol. Demographic and cardiovascular risk factors were considered as determinants of awareness and accuracy. Accuracy was evaluated by the difference between reported and measured cholesterol. In addition, we examined the relationship of self-reported cholesterol with incident CVD over 10 years.

Results

Compared with women who were unaware of their cholesterol levels, aware women (84%) had higher levels of income, education, and exercise and were more likely to be married, normal in weight, treated for hypertension and hypercholesterolemia, nonsmokers, moderate drinkers, and users of hormone therapy. Women underestimated their total cholesterol by 9.7 mg/dL (95% CI: 9.2–10.2); covariates explained little of this difference (R 2 < .01). Higher levels of self-reported cholesterol were strongly associated with increased risk of CVD, which occurred in 741 women (hazard ratio 1.23/40 mg/dL cholesterol, 95% CI: 1.15–1.33). Women with elevated cholesterol who were unaware of their level had particularly increased risk (HR=1.88, P <. 001) relative to aware women with normal measured cholesterol.

Conclusion

Women with obesity, smoking, untreated hypertension, or sedentary lifestyle have decreased awareness of their cholesterol levels. Self-reported cholesterol underestimates measured values, but is strongly related to CVD. Lack of awareness of elevated cholesterol is associated with increased risk of CVD.
Literature
1.
go back to reference Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.CrossRef Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–97.CrossRef
2.
go back to reference National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation. 1994;89:1333–445. National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation. 1994;89:1333–445.
3.
go back to reference U.S. Department of Health and Human Services. Healthy People 2010. 2nd ed. With Understanding and Improving Health and Objectives for Improving Health. 2 vols. Washington, DC: U.S. Government Printing Office; 2000. U.S. Department of Health and Human Services. Healthy People 2010. 2nd ed. With Understanding and Improving Health and Objectives for Improving Health. 2 vols. Washington, DC: U.S. Government Printing Office; 2000.
4.
go back to reference Centers for Disease Control and Prevention. Progress in chronic disease prevention factors related to cholesterol screening and cholesterol level awareness—United States, 1989. MMWR Morb Mortal Wkly Rep. 1990;39:633–7. Centers for Disease Control and Prevention. Progress in chronic disease prevention factors related to cholesterol screening and cholesterol level awareness—United States, 1989. MMWR Morb Mortal Wkly Rep. 1990;39:633–7.
5.
go back to reference Schucker B, Wittes J, Santanello N, et al. Change in cholesterol awareness and action: results from national physician and public surveys. Arch Intern Med. 1991;151:666–73.PubMedCrossRef Schucker B, Wittes J, Santanello N, et al. Change in cholesterol awareness and action: results from national physician and public surveys. Arch Intern Med. 1991;151:666–73.PubMedCrossRef
6.
go back to reference Pieper RM, Arnett DK, McGovern PG, Shahar E, Blackburn H, Luepker RV. Trend in cholesterol knowledge and screening and hypercholesterolemia awareness and treatment, 1980–1992: the Minnesota Heart Survey. Arch Intern Med. 1997;157:2326–32.PubMedCrossRef Pieper RM, Arnett DK, McGovern PG, Shahar E, Blackburn H, Luepker RV. Trend in cholesterol knowledge and screening and hypercholesterolemia awareness and treatment, 1980–1992: the Minnesota Heart Survey. Arch Intern Med. 1997;157:2326–32.PubMedCrossRef
7.
go back to reference Nash IS, Mosca L, Blumenthal RS, Davidson MH, Smith SC, Pasternak RC. Contemporary awareness and understanding of cholesterol as a risk factor. Arch Intern Med. 2003;163:1597–1600.PubMedCrossRef Nash IS, Mosca L, Blumenthal RS, Davidson MH, Smith SC, Pasternak RC. Contemporary awareness and understanding of cholesterol as a risk factor. Arch Intern Med. 2003;163:1597–1600.PubMedCrossRef
8.
go back to reference Nieto FJ, Alonso J, Chambless L, et al. Population awareness and control of hypertension and hypercholesterolemia. The Atherosclerosis Risk in Communities study. Arch Intern Med. 1995;155:677–84.PubMedCrossRef Nieto FJ, Alonso J, Chambless L, et al. Population awareness and control of hypertension and hypercholesterolemia. The Atherosclerosis Risk in Communities study. Arch Intern Med. 1995;155:677–84.PubMedCrossRef
9.
go back to reference Centers for Disease Control and Prevention. State-specific cholesterol screening trends—United States, 1991–1999. MMWR Morb Mortal Wkly Rep. 2000;49:750–5. Centers for Disease Control and Prevention. State-specific cholesterol screening trends—United States, 1991–1999. MMWR Morb Mortal Wkly Rep. 2000;49:750–5.
10.
go back to reference Centers for Disease Control and Prevention. Cholesterol screening and awareness—Behavioral Risk Factor Surveillance System, 1990. MMWR Morb Mortal Wkly Rep. 1992;41(36). Centers for Disease Control and Prevention. Cholesterol screening and awareness—Behavioral Risk Factor Surveillance System, 1990. MMWR Morb Mortal Wkly Rep. 1992;41(36).
11.
go back to reference Mosca L, Ferris A, Fabunmi R, Robertson RM. Tracking women’s awareness of heart disease—an American Heart Association National Study. Circulation 2004;109:573–9PubMedCrossRef Mosca L, Ferris A, Fabunmi R, Robertson RM. Tracking women’s awareness of heart disease—an American Heart Association National Study. Circulation 2004;109:573–9PubMedCrossRef
12.
go back to reference Bowlin SJ, Morrill BD, Nafziger AN, Jenkins PL, Lewis C, Pearson TA. Validity of cardiovascular disease risk factors assess by telephone survey: the Behavioral Risk Factor Study. J Clin Epidemiol. 1993;46:561–71.PubMedCrossRef Bowlin SJ, Morrill BD, Nafziger AN, Jenkins PL, Lewis C, Pearson TA. Validity of cardiovascular disease risk factors assess by telephone survey: the Behavioral Risk Factor Study. J Clin Epidemiol. 1993;46:561–71.PubMedCrossRef
13.
go back to reference Bowlin S, Morrill B, Nafziger A, Lewis C, Pearson T. Reliability and changes in validity of self-reported cardiovascular disease risk factors using dual response: The Behavioral Risk Factor Survey. J Clin Epidemiol. 1996;49:511–7.PubMedCrossRef Bowlin S, Morrill B, Nafziger A, Lewis C, Pearson T. Reliability and changes in validity of self-reported cardiovascular disease risk factors using dual response: The Behavioral Risk Factor Survey. J Clin Epidemiol. 1996;49:511–7.PubMedCrossRef
14.
go back to reference Natarajan S, Lipsitz SR, Nietert PJ. Self-report of high cholesterol-determinants of validity in U.S. adults. Am J Prev Med. 2002;23:13–21.PubMedCrossRef Natarajan S, Lipsitz SR, Nietert PJ. Self-report of high cholesterol-determinants of validity in U.S. adults. Am J Prev Med. 2002;23:13–21.PubMedCrossRef
15.
go back to reference Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986;123:894–900.PubMed Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986;123:894–900.PubMed
16.
go back to reference Newell S, Girgis A, Sanson-Fisher R, Ireland M. Accuracy of patients’ recall of Pap and cholesterol screening. Am J Public Health. 2000;90:1431–5.PubMedCrossRef Newell S, Girgis A, Sanson-Fisher R, Ireland M. Accuracy of patients’ recall of Pap and cholesterol screening. Am J Public Health. 2000;90:1431–5.PubMedCrossRef
17.
go back to reference Murdoch M, Wilt TJ. Cholesterol awareness after case-finding: do patients really know their cholesterol numbers? Am J Prev Med. 1997;13:284–9.PubMed Murdoch M, Wilt TJ. Cholesterol awareness after case-finding: do patients really know their cholesterol numbers? Am J Prev Med. 1997;13:284–9.PubMed
18.
go back to reference Bairey Merz CN, Felando MN, Klein J. Cholesterol awareness and treatment in patients with coronary artery disease participating in cardiac rehabilitation. J Cardiopulm Rehabil. 1996;16:117–22.PubMedCrossRef Bairey Merz CN, Felando MN, Klein J. Cholesterol awareness and treatment in patients with coronary artery disease participating in cardiac rehabilitation. J Cardiopulm Rehabil. 1996;16:117–22.PubMedCrossRef
19.
go back to reference Rexrode KM, Lee I, Cook NR, Hennekens CH, Buring JE. Baseline characteristics of participants in the Women’s Health Study. J Womens Health Gend Based Med. 2000;9:19–27.PubMedCrossRef Rexrode KM, Lee I, Cook NR, Hennekens CH, Buring JE. Baseline characteristics of participants in the Women’s Health Study. J Womens Health Gend Based Med. 2000;9:19–27.PubMedCrossRef
20.
go back to reference Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352:1293–304.PubMedCrossRef Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005;352:1293–304.PubMedCrossRef
21.
go back to reference Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer. The Women’s Health Study: a randomized controlled trial. JAMA 2005;294:47–55.PubMedCrossRef Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer. The Women’s Health Study: a randomized controlled trial. JAMA 2005;294:47–55.PubMedCrossRef
22.
go back to reference Hosmer DW, Lemeshow S. Applied Logistic Regression, 2nd edition. New York: John Wiley and Sons; 2000. Hosmer DW, Lemeshow S. Applied Logistic Regression, 2nd edition. New York: John Wiley and Sons; 2000.
23.
go back to reference Harawa NT, Morgenstern H, Beck J, Moore A. Correlates of knowledge of one’s blood pressure and cholesterol levels among older members of a managed care plan. Aging. 2001;13:95–104.PubMed Harawa NT, Morgenstern H, Beck J, Moore A. Correlates of knowledge of one’s blood pressure and cholesterol levels among older members of a managed care plan. Aging. 2001;13:95–104.PubMed
24.
go back to reference Nelson K, Norris K, Mangione CM. Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity—data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2002;162:929–35PubMedCrossRef Nelson K, Norris K, Mangione CM. Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity—data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2002;162:929–35PubMedCrossRef
25.
go back to reference Brennan RM, Crespo CJ, Wactawski-Wende J. Health behaviors and other characteristics of women on hormone therapy: results from the Third National Health and Nutrition Examination Survey, 1988–1994. Menopause 2004;11:536–42.PubMedCrossRef Brennan RM, Crespo CJ, Wactawski-Wende J. Health behaviors and other characteristics of women on hormone therapy: results from the Third National Health and Nutrition Examination Survey, 1988–1994. Menopause 2004;11:536–42.PubMedCrossRef
Metadata
Title
Awareness, Accuracy, and Predictive Validity of Self-Reported Cholesterol in Women
Authors
Peng-yun A. Huang, MBBS, MPH
Julie E. Buring, ScD
Paul M. Ridker, MD, MPH
Robert J. Glynn, PhD, ScD
Publication date
01-05-2007
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 5/2007
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0144-1

Other articles of this Issue 5/2007

Journal of General Internal Medicine 5/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.